<!DOCTYPE html>
<html lang="en">
<head id="Head1">
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />
    <meta http-equiv="content-type" content="text/html;charset=utf-8" />
    <meta http-equiv="X-UA-Compatible" content="IE=Edge" />
    <meta charset="utf-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />
    <title>Full Text of HB1910</title>
    <link rel="shortcut icon" type="image/x-icon" href="https://cdn.ilga.gov/assets/img/site/favicon.ico" />
    <link rel="stylesheet" href="https://cdn.ilga.gov/assets/css/bootstrap/bootstrap-4.6.2-dist/css/bootstrap.min.css" />
    <link href="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/bootstrap-table.min.css" rel="stylesheet">
    <link href="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/extensions/filter-control/bootstrap-table-filter-control.min.css" rel="stylesheet">
    <link href="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/extensions/filter-control/bootstrap-table-filter-control.min.css" rel="stylesheet">
    <script src="https://cdn.ilga.gov/assets/js/fontawesome/fa.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/jquery/jquery.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/jquery/js.cookie.min.js"></script>
    <script async src="https://cse.google.com/cse.js?cx=a47f92b5e11c1499a"></script> 
    <!-- Bootstrap Datepicker CSS -->
    <link rel="stylesheet" href="https://cdn.ilga.gov/assets/css/bootstrap/bootstrap-4.6.2-dist/css/bootstrap-datepicker.min.css">
    <!-- Bootstrap Datepicker JavaScript -->
    <script src="https://cdn.ilga.gov/assets/js/bootstrap/bootstrap-datepicker.min.js"></script>
    <!-- aos, bootstrap icons, swiper CSS -->
    <link href="https://cdn.ilga.gov/assets/css/aos/aos.css" rel="stylesheet">
    <link href="https://cdn.ilga.gov/assets/css/swiper/swiper-bundle.min.css" rel="stylesheet">

    <script src="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/bootstrap-table.min.js"></script>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/extensions/filter-control/bootstrap-table-filter-control.min.js"></script>

    <!-- ILGA main CSS -->
    <link rel="stylesheet" href="https://cdn.ilga.gov/main.css" />
    <link rel="stylesheet" type="text/css" media="print" href="https://cdn.ilga.gov/assets/css/print.css">
    <style></style>
    
</head>
<body>
        <!-- ======= Header ======= -->
        <header id="print-header" class="d-flex align-items-center">
            <div class="container-fluid align-items-center text-uppercase justify-content-start ">
                <div class="logo ">
                    <a href="/"><img src="https://cdn.ilga.gov/assets/img/site/white_capitol.png" alt="ILGA Logo"><span>ILGA.GOV</span></a>
                </div>
                <div class="w-100"></div>
            </div>
        </header>
    <input id="TextSearch" type="hidden" />
    <input id="MobileTextSearch" type="hidden" />
    <input id="message-input" type="hidden" />

    <main id="main-content" role="main">
        <section class="main-page p-2">
	<div class="p-1 pt-4 float-left">
		<div class="row border-bottom pb-3 mb-3">
			<div class="text-start">
				<h2>
					HB1910 - 104th General Assembly
				</h2><br />
			</div>
		</div>
		<div id="content">
			<!-- Full text only shows on large screens -->
			<div class="centered-container d-lg-flex">
				<div class="left-aligned-content">
					<div class="row">
						<div class="col pl-lg-5" translate="no">
							<text class="ml-5 text-left fulltextLineHeight" id="billtextanchor">
								<style>
								
								
								
								table.xsl	{ 	border-collapse: collapse;
												border: 0px solid black;
												font-family: "courier New"; 
												font-size: 10pt;}
								
								td.xsl		{ 	border-collapse: collapse;
												border: 0px solid black;
												padding-top: 3pt;
												padding-bottom: 3pt;
												padding-left: 0pt;
												padding-right: 0pt;
												font-family: "courier New"; 
												font-size: 10pt; }
												
								td.junk		{ 	width: 5%; }
								 
							
					
					
						body.xsl		{ 	text-align:center; }
						
					
						td.lineNum 		{ 	vertical-align: top; 
										  	text-align: right;
										  	font-family: "courier New"; 
										  	font-size: 10pt; }
							
						td.number 		{	width: 5%;
											vertical-align: top; 
										  	text-align: right;
										  	font-family: "Courier New", sans-serif;
										  	font-size: 10pt; }
						
						td.synopsis		{ 	border-collapse: collapse;
											border: 0px solid black;
											padding-top: 0pt;
											padding-bottom: 0pt;
											padding-left: 0pt;
											padding-right: 0pt;
											font-family: "courier New"; 
											font-size: 10pt; }
						
						td.rowsep		{ 	border-bottom: 1px solid black; }
											
						td.colsep		{ 	border-right: 1px solid black; }
											
						td.bothsep		{ 	border-right: 1px solid black;
										  	border-bottom: 1px solid black; }
	
						table.top		{ 	font-family: "Courier New", sans-serif;
									  	  	font-size: 10pt;
									  	  	border-top: 1px solid black; }
											
						table.bottom	{ 	font-family: "Courier New", sans-serif;
									  	  	font-size: 10pt;
									  	  	border-bottom: 1px solid black; }
											
						table.sides		{ 	font-family: "Courier New", sans-serif;
									  	  	font-size: 10pt;
									  	  	border-left: 1px solid black;
									  	  	border-right: 1px solid black; }
	
						table.all		{ 	font-family: "Courier New", sans-serif;
										  	font-size: 10pt;
									  	  	border-left: 1px solid black;
									  	  	border-right: 1px solid black;
									  	  	border-bottom: 1px solid black;
									  	  	border-top: 1px solid black; }				
	
						table.topbot	{ 	border-collapse: separate;
									  	  	border: outset 0pt;
										  	font-family: "Courier New", sans-serif;
									  	  	font-size: 10pt;
									  	  	border-top: 1px solid black;
									  	  	border-bottom: 1px solid black; }
					
						.sigline		{ 	text-align: left;
							 		 		vertical-align: bottom;
							 				padding-top: 3pt;
							 				padding: 0pt; }
							 				
						.siglinetext		{ 	text-align: left;
							 		 		vertical-align: top;
							 				padding-top: 3pt;
							 				padding: 0pt; }
							 				
						.sigtitle		{ 	text-align: left;
							 				vertical-align: top;
							 				padding: 0pt; }
							 				  
						.sigtitlenum		{ 	text-align: right;
							 				vertical-align: top;
							 				padding: 0pt; }
							
						.siglinenum		{ 	text-align: right;
							 				vertical-align: center;
							 				padding-top: 3pt;
							 				padding: 0pt; }
					</style><table class="xsl" width="578"><pre><tr><td class="xsl" colspan="3"><p> </p><br> </td></tr></td></tr><tr><td class="number"></td><td class="junk"></td><td class="xsl"><table class="xsl" width="100%"><tr><td class="xsl"><center><b><pre><font size="3" face="Courier New">104TH GENERAL ASSEMBLY
State of Illinois
2025 and 2026</font><br>HB1910</pre></b></center><p> </p>Introduced 1/29/2025, by Rep. Anna Moeller<p> </p><b>SYNOPSIS AS INTRODUCED:</b><br> </td></tr><tr><td class="xsl"></td></tr><tr><td class="xsl"><table class="xsl" width="100%"><colgroup width="50%"></colgroup><colgroup width="50%"></colgroup><tr><td class="synopsis"><code>75 ILCS 5/1-8 new</code></td><td class="synopsis"></td></tr><tr><td class="synopsis"><code>225 ILCS 85/19.1</code></td><td class="synopsis"></td></tr></table><p></p></td></tr><tr><td class="xsl"><code>    </code><code>Amends the Illinois Local Library Act. Provides that all libraries </code><code>open to the general public in the State shall maintain a supply of opioid </code><code>antagonists in an accessible location. Provides that any authorized </code><code>personnel may administer an opioid antagonist to any person whom the </code><code>authorized personnel believes, in good faith, to be having an opioid </code><code>overdose (i) on library grounds; (ii) in the immediate vicinity of the </code><code>library; or (iii) at a library-sponsored event. Requires libraries to </code><code>ensure that during all operating hours, there is at least one person </code><code>present in the library who has completed training in how to recognize and </code><code>respond to an opioid overdose, including the administration of an opioid </code><code>antagonist. Requires the Director of the Department of Public Health to </code><code>identify organizations qualified to offer the training. Provides that the </code><code>health department of any county where a Library is located may provide, </code><code>either directly or through providing necessary funds, a supply of opioid </code><code>antagonists to the library. Allows the Department to adopt rules to </code><code>implement the provisions. Makes conforming changes in the Pharmacy </code><code>Practice Act.</code></td></tr><tr align="right" class="lineNum"><td class="xsl"><br><br></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left"></td><td class="xsl" align="center"></td><td class="xsl" align="right">LRB104 08994 RTM 19050 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="xsl"></td></tr><tr><td class="xsl"><p> </p><p> </p><center><b>A BILL FOR</b></center><p></p></td></tr></table><p> </p></td></tr><tr><td class="xsl"></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB1910</td><td class="xsl" align="center"></td><td class="xsl" align="right">LRB104 08994 RTM 19050 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>    </code><code>AN ACT concerning local government.</code><br> </td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>    </code><b><code>Be it enacted by the People of the State of Illinois, </code></b></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><b><code>represented in the General Assembly:</code></b><br> </td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Section 5. </code><code>The Illinois Local Library Act is amended by </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>adding Section 1-8 as follows:</code><br> </td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(75 ILCS 5/1-8 new)</code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>    </code><u><code>Sec. 1-8. </code></u><u><code>Opioid antagonists.</code></u></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>    </code><u><code>(a) As used in this Section:</code></u></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>    </code><u><code>"Authorized personnel" means an employee of the library </code></u></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><u><code>who has completed training under subsection (d) of this </code></u></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><u><code>Section.</code></u></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>    </code><u><code>"Department" means the Department of Public Health.</code></u></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>    </code><u><code>"Library" means a public library established under or </code></u></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><u><code>otherwise subject to the requirements of this Act.</code></u></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>    </code><u><code>"Opioid antagonist" means a drug approved by the federal </code></u></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><u><code>Food and Drug Administration or recommended for use by the </code></u></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><u><code>World Health Organization that, when administered, negates or </code></u></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><u><code>neutralizes in whole or in part the pharmacological effects of </code></u></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><u><code>an opioid in the body. "Opioid antagonist" shall be limited to </code></u></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><u><code>naloxone and other medications approved by the Department for </code></u></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><u><code>such purpose.</code></u></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>    </code><u><code>(b) All libraries open to the general public in the State </code></u></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><u><code>shall maintain a supply of opioid antagonists in an accessible </code></u></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB1910</td><td class="xsl" align="center">- 2 -</td><td class="xsl" align="right">LRB104 08994 RTM 19050 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><u><code>location.</code></u></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>    </code><u><code>(c) Any authorized personnel may administer an opioid </code></u></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><u><code>antagonist to any person whom the authorized personnel </code></u></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><u><code>believes, in good faith, to be having an opioid overdose (i) on </code></u></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><u><code>library grounds, (ii) in the immediate vicinity of the </code></u></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><u><code>library, or (iii) at a library-sponsored event. Authorized </code></u></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><u><code>personnel may carry an opioid antagonist while in the library </code></u></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><u><code>or at a library-sponsored activity.</code></u></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>    </code><u><code>(d) Libraries shall ensure that, during all operating </code></u></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><u><code>hours, there is at least one person present in the library who </code></u></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><u><code>has completed training in how to recognize and respond to an </code></u></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><u><code>opioid overdose, including the administration of an opioid </code></u></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><u><code>antagonist. This training shall be conducted by an </code></u></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><u><code>organization recognized for providing such training, and may </code></u></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><u><code>be conducted online or in person. The training must comply </code></u></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><u><code>with any training requirements under Section 5-23 of the </code></u></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><u><code>Substance Use Disorder Act and the corresponding rules. The </code></u></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><u><code>training must also include, but shall not be limited to:</code></u></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><u><code>(1) information on how to recognize symptoms of an </code></u></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" >    <u><code>opioid overdose;</code></u></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><u><code>(2) information on drug overdose prevention and </code></u></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" >    <u><code>recognition;</code></u></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><u><code>(3) information on how to perform rescue breathing and </code></u></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" >    <u><code>resuscitation;</code></u></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><u><code>(4) information on how to respond to an emergency </code></u></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" >    <u><code>involving an opioid overdose;</code></u></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB1910</td><td class="xsl" align="center">- 3 -</td><td class="xsl" align="right">LRB104 08994 RTM 19050 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><u><code>(5) information on opioid antagonist dosage and </code></u></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" >    <u><code>administration;</code></u></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><u><code>(6) information on the importance of calling 9-1-1 or, </code></u></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" >    <u><code>if 9-1-1 is not available, other local emergency medical </code></u></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" >    <u><code>services;</code></u></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><u><code>(7) information on care for the overdose victims after </code></u></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" >    <u><code>administration of the overdose antagonist;</code></u></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><u><code>(8) a test demonstrating competency of the knowledge </code></u></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" >    <u><code>required to recognize an opioid overdose and administer a </code></u></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" >    <u><code>dose of an opioid antagonist; and</code></u></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><u><code>(9) other criteria determined by the Department.</code></u></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>    </code><u><code>(e) The Director of the Department shall identify </code></u></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><u><code>organizations qualified to offer the training required by </code></u></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><u><code>subsection (d) of this Section, and shall make a list of such </code></u></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><u><code>organizations available on the Department's website.</code></u></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>    </code><u><code>(f) The health department of any county where a Library is </code></u></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><u><code>located may provide, either directly or by providing necessary </code></u></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><u><code>funds, a supply of opioid antagonists to the library. A </code></u></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><u><code>library that receives opioid antagonists under this subsection </code></u></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><u><code>(f) shall be considered to be in compliance with subsection </code></u></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><u><code>(b) of this Section.</code></u></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>    </code><u><code>(g) The Department may adopt rules as necessary to </code></u></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><u><code>implement this Section, including, but not limited to, rules </code></u></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><u><code>establishing additional training curriculum criteria as </code></u></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><u><code>described in subsection (d) of this Section.</code></u><br> </td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB1910</td><td class="xsl" align="center">- 4 -</td><td class="xsl" align="right">LRB104 08994 RTM 19050 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Section 10. </code><code>The Pharmacy Practice Act is amended by </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>changing Section 19.1 as follows:</code><br> </td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(225 ILCS 85/19.1)</code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(Section scheduled to be repealed on January 1, 2028)</code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Sec. 19.1. </code><code>Dispensing opioid antagonists.</code><code> </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(a) Due to the recent rise in opioid-related deaths in </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>Illinois and the existence of an opioid antagonist that can </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>reverse the deadly effects of overdose, the General Assembly </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>finds that in order to avoid further loss where possible, it is </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>responsible to allow greater access of such an antagonist to </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>those populations at risk of overdose.</code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(b) Notwithstanding any general or special law to the </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>contrary, a licensed pharmacist shall dispense an opioid </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>antagonist in accordance with written, standardized procedures </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>or protocols developed by the Department with the Department </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>of Public Health and the Department of Human Services and </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>filed at the pharmacy before implementation and are available </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>to the Department upon request. </code><u><code>This includes dispensation of </code></u></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><u><code>opioid antagonists to public libraries under Section 1-8 of </code></u></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><u><code>the Illinois Local Library Act.</code></u><code> </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(c) Before dispensing an opioid a pharmacist shall inform </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>patients that opioids are addictive and offer to dispense an </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>opioid antagonist.</code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(d) For the purpose of this Section, "opioid antagonist" </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>means a drug that binds to opioid receptors and blocks or </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB1910</td><td class="xsl" align="center">- 5 -</td><td class="xsl" align="right">LRB104 08994 RTM 19050 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>inhibits the effect of opioids acting on those receptors, </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>including, but not limited to, naloxone hydrochloride or any </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>other similarly acting and equally safe drug approved by the </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>U.S. Food and Drug Administration for the treatment of drug </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>overdose.</code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>(Source: P.A. 102-1040, eff. 1-1-23</code><code>.)</code></pre></table>
							</text>
						</div>
					</div>
				</div>
			</div>
		</div>
    </div>
</section>
    </main>
    <!-- Vendor JS Files -->
    <script src="https://cdn.ilga.gov/assets/js/aos/aos.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/jquery/popper.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/bootstrap/bootstrap.bundle.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/glightbox/glightbox.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/swiper/swiper-bundle.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/main.js"></script>

    

</body>
</html>
